Your browser doesn't support javascript.
loading
Functional CD3+CD8+PD1- T Cell Accumulation and PD-L1 Expression Increases During Tumor Invasion in DCIS of the Breast.
Lv, Shuzhen; Wang, Shuo; Qiao, Guoliang; Wang, Xiaoli; Zhou, Xinna; Yan, Fengcai; Li, Yanping; Wang, Suya; Morse, Michael A; Hobeika, Amy; Ren, Jun; Lyerly, Herbert Kim.
Afiliação
  • Lv S; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; Department of Breast Surgical Oncology, Capital Medical University Cancer Center, Beijing Shijitan
  • Wang S; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Qiao G; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Wang X; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhou X; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Yan F; Department of Pathology, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Li Y; Department of Breast Surgical Oncology, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Wang S; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Morse MA; Department of Medicine, Duke University Medical Center, Durham, NC; Department of Surgery, Duke University Medical Center, Durham, NC.
  • Hobeika A; Department of Surgery, Duke University Medical Center, Durham, NC.
  • Ren J; Department of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; Department of Surgery, Duke University Medical Center, Durham, NC. Electronic address: jun.ren@duke
  • Lyerly HK; Department of Surgery, Duke University Medical Center, Durham, NC. Electronic address: kim.lyerly@duke.edu.
Clin Breast Cancer ; 19(5): e617-e623, 2019 10.
Article em En | MEDLINE | ID: mdl-31101455

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos do Interstício Tumoral / Complexo CD3 / Carcinoma Intraductal não Infiltrante / Linfócitos T CD8-Positivos / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos do Interstício Tumoral / Complexo CD3 / Carcinoma Intraductal não Infiltrante / Linfócitos T CD8-Positivos / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Ano de publicação: 2019 Tipo de documento: Article